Schriftgröße ändern
  • Markets
  • News
  • Search
  • AA
Overview Chart Times&Sales News
GENMAB AS DK 1 273.00 / -2.60%
Date/Time 03/03 / 12:12
Chg. / Chg.(%) -7.30 / -2.60%
Bid 273.00
Ask 273.70
Open 280.30
Previous Close 280.30
High 281.30
Low 273.00
Volume [EUR] -
Volume [Units]
Price fixings 2043
ISIN DK0010272202
Security GE9
Exchange Lang & Schwarz
Type Stock

Other Exchanges

Exchange Last Volume
Cboe Europe .. 2,034.00 Diff. akt. K. - Schluss Vort. > -1% 25,884
Turquoise 2,034.00 Diff. akt. K. - Schluss Vort. > -1% 6,564
London Inter.. 2,036.0 Diff. akt. K. - Schluss Vort. > -1% 3,066
Cboe Europe .. 2,043.50 Diff. akt. K. - Schluss Vort. > -1% 146
TradeGate 272.500 Diff. akt. K. - Schluss Vort. > -1% 82
Cboe Europe .. 2,045.00 Diff. akt. K. - Schluss Vort. > -1% 65
Frankfurt 275.2000 Diff. akt. K. - Schluss Vort. > -1% 12
gettex 272.600 Diff. akt. K. - Schluss Vort. > -1% 3
Vienna Globa.. 278.20 Diff. akt. K. - Schluss Vort. > -1% 0
München 284.70 Diff. akt. K. - Schluss Vort. > -1% 0
Düsseldorf 273.50 Diff. akt. K. - Schluss Vort. > -1% 0
Berlin 274.00 Diff. akt. K. - Schluss Vort. > -1% 0
Lang & Schwa.. 273.00 Diff. akt. K. - Schluss Vort. > -1%
Stuttgart 274.800 Diff. akt. K. - Schluss Vort. > -1%
OMX Nordic 2,102.00 Diff. akt. K. - Schluss Vort. > -1% 189,102
Nasdaq Other.. 338.2800 Diff. akt. K. - Schluss Vort. > -1% 372
Mexico 7,638.15 Diff. akt. K. - Schluss Vort. > -1% 11,330

News

  • Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
    02/25/2021 / 20:53 - GlobeNewswire
  •  
  • Genmab announces initiation of share buy-back program
    02/23/2021 / 17:05 - GlobeNewswire
  •  
  • Genmab Publishes 2020 Annual Report
    02/23/2021 / 17:00 - GlobeNewswire
  •  
  • Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
    02/22/2021 / 14:00 - GlobeNewswire
  •  
  • Genmab and Seagen Submit Tisotumab Vedotin Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer
    02/10/2021 / 22:05 - GlobeNewswire

Personal area

  • Add to watchlist
  •  
  • Add notification
  •  
  • Add to portfolio
  •  
  • Recommend Website

Market Overview>>

Currencies Real-time>>

Interest rates>>

Commodities>>

Futures>>

All quote information is delayed depending on the regulations of the selected stock exchange, in general 15 minutes or more. Terms of Use | Legal Notice | Recommend Website | Feedback | Go to full version (www.teletrader.com)